System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Fernando Gómez-Peralta is an expert in Endocrinology at Hospital General De Segovia (Spain). As of October 2026, ScienceLeadR ranks Fernando Gómez-Peralta in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders. Fernando Gómez-Peralta has authored 132 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 688 (community average: 125). How the SLR is computed.

LeadR Profile

Fernando Gómez-Peralta Hospital General De Segovia Spain
688 ScienceLeadR Reputation 688

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Biochemistry - Public Health - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Fernando Gómez-Peralta is Head of the Unit of Endocrinology, Diabetes and Nutrition at Hospital General de Segovia, Spain. He received his medical degree (MD) in 1993 from the Universidad de Navarra. Pamplona (Spain). Doctor in Medicine (PhD) in 2000 from Universidad de Navarra. Pamplona (Spain).

Coordinator for the Diabetes Area of the Spanish Endocrinology and Nutrition Society (SEEN).

He is a member of the Spanish Diabetes Association, Spanish Society of Endocrinology and Nutrition and the American Diabetes Association. Vice-President and Diabetes Group Coordinator for the Sociedad Castellano-Leonesa de Endocrinología, Diabetes y Nutrición. Secretary of Spanish Diabetes Association (April 2014 – May 2018). Member of Consensus and Guidelines Workgroup of Spanish Diabetes Association and Diabetes Group of the Spanish Endocrinology and Nutrition Association.

FGP has authored and co-authored publications in peer-reviewed journals (Diabetes Care, Diabetes Obesity and Metabolism, Diabetic Medicine, Diabetes Research and Clinical Practice, Journal of Diabetes and Its Complications, BMC Endocrine Fernando Gómez-Peralta is Head of the Unit of Endocrinology, Diabetes, and Nutrition at Hospital General de Segovia, Spain. He received his medical degree in 1993 from the Universidad de Navarra, Pamplona (Spain), and earned his Doctor of Medicine (MD) degree in 2000 from the same university.


He is Coordinator for the Diabetes Area of the Spanish Endocrinology and Nutrition Society (SEEN) and a member of the Spanish Diabetes Association, the Spanish Society of Endocrinology and Nutrition, and the American Diabetes Association. He serves as Vice-President and Diabetes Group Coordinator for the Sociedad Castellano-Leonesa de Endocrinología, Diabetes y Nutrición. He was Secretary of the Spanish Diabetes Association from April 2014 to May 2018 and is a member of the Consensus and Guidelines Workgroup of the Spanish Diabetes Association, as well as the Diabetes Group of the Spanish Endocrinology and Nutrition Association.



His research interests include diabetes technology, continuous glucose monitoring, smart pens, the epidemiology of diabetes and its complications, insulin secretion and insulin resistance, and clinical therapeutics of diabetes.

Organizations

Career arc: 2012 - 2026
Source: PubMed

Hospital General De Segovia

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 132

Citations

Citations: 9 014 1st author: 54 Last author: 11 Unique author: 1

Main journals

Diabetes Ther 12
Diabetes 10
Endocrinol Diabetes Nutr (Engl Ed) 9
Diabetes Technol Ther 7
J Clin Med 7

Best Journals

Ann Oncol 1
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Continuous Glucose Monitoring and Hospitalization Outcomes in Adults with Insulin-Treated Type 2 Diabetes and Complex Care Needs: A Population-Based Study.
PMID 42786775 — diabetes mellitus, hospitalization, insulin, multimorbidity, diabetes mellitus, type 2, continuous glucose monitoring		Diabetes Technol Ther20260
Real-World Long-Term Safety of Statin-Fibrate Combination Therapy in Older Patients (≥75 Years): A European Cohort Analysis.
PMID 42776724 — diabetes mellitus, safety, incidence, dyslipidemias, pravastatin, aged, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, fenofibrate		Geriatrics (Basel)20260
Improvement in insulin injection timing and glucometrics using a connected insulin cap: the prospective study.
PMID 42528822 — diabetes mellitus, injections, insulin, meals, prospective studies, endocrine system diseases		Front Endocrinol (Lausanne)20260
Low-density lipoprotein cholesterol management and goal attainment at 1 year in patients with diabetes, pre-diabetes and normoglycaemia: results from the European, prospective, observational SANTORINI study.
PMID 42373176 — diabetes mellitus, cholesterol, ldl, lipoproteins, cholesterol, therapeutics, lipoproteins, ldl		BMJ Open20260
Implementation of Intermittently Scanned Continuous Glucose Monitoring and Changes in Hospitalizations and Health Care Costs in Insulin-Treated Type 2 Diabetes.
PMID 42301188 — diabetes mellitus, health care costs, hospitalization, insulin, length of stay, diabetes mellitus, type 2, continuous glucose monitoring		Diabetes Care20261

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 3 4
N/A 2
Phase 4 1

By status:

Completed 6
Recruiting 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 6

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774 — lipoproteins, cardiovascular diseases, atherosclerosis, lipoprotein(a)		Phase 3Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS